Day One Biopharmaceuticals, Inc. (DAWN)
9.25
-0.36
(-3.75%)
USD |
NASDAQ |
Jan 08, 16:00
9.25
0.00 (0.00%)
After-Hours: 20:00
Day One Biopharmaceuticals Research and Development Expense (Annual): 227.70M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Mersana Therapeutics, Inc. | 73.02M |
| Perspective Therapeutics, Inc. | 39.33M |
| Electromed, Inc. | 0.996M |
| InfuSystem Holdings, Inc. | -- |
| Xtant Medical Holdings, Inc. | 2.385M |